Cheryl Renz

2.1k total citations · 1 hit paper
27 papers, 1.5k citations indexed

About

Cheryl Renz is a scholar working on Infectious Diseases, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cheryl Renz has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Pharmacology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cheryl Renz's work include Pharmacology and Obesity Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Pregnancy and Medication Impact (4 papers). Cheryl Renz is often cited by papers focused on Pharmacology and Obesity Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Pregnancy and Medication Impact (4 papers). Cheryl Renz collaborates with scholars based in United States, United Kingdom and Chile. Cheryl Renz's co-authors include Nick Finer, Richard A. Rode, Arya M. Sharma, Luc F. Van Gaal, Walmir Coutinho, Ian D. Caterson, Aldo P. Maggioni, Christian Torp‐Pedersen, W. P. T. James and Gillian Shepherd and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Biochemical Journal.

In The Last Decade

Cheryl Renz

25 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

2010 676 citations W. P. T. James, Ian D. Caterson et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Cheryl Renz

Since Specialization

Citations

This map shows the geographic impact of Cheryl Renz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Renz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Renz more than expected).

Fields of papers citing papers by Cheryl Renz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Renz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Renz. The network helps show where Cheryl Renz may publish in the future.

Co-authorship network of co-authors of Cheryl Renz

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Renz. A scholar is included among the top collaborators of Cheryl Renz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Renz. Cheryl Renz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Understanding willingness and barriers to participate in clinical trials during pregnancy and lactation: findings from a US study	BMC Pregnancy and Childbirth	Melanie H. Jacobson, Cheryl Renz et al.	1
2	Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry	Drug Safety	Diego F. Wyszynski, Cheryl Renz et al.	0
3	A Survey to Assess the Current Status of Structured Benefit-Risk Assessment in the Global Drug and Medical Device Industry	Therapeutic Innovation & Regulatory Science	Martin Gebel, Cheryl Renz et al.	3
4	The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations	Drug Safety	Diego F. Wyszynski, Mondira Bhattacharya et al.	3
5	The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations	Drug Safety	Diego F. Wyszynski, Aris T. Papageorghiou et al.	1
6	Klippel-Trenaunay-Weber syndrome: Oro-dental manifestations and management	International Journal of Surgery Case Reports	Cheryl Renz, Johannes Kleinheinz et al.	1
7	Risk Minimization of Antibody–Drug Conjugates in Oncology: A Review	Drug Safety	Fabio Lievano, Jerzy E. Tyczynski et al.	8
8	Patient Preferences for Endometriosis Pain Treatments in the United States	Value in Health	Christine Poulos, Ahmed M. Soliman et al.	12
9	Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial	Diabetes Obesity and Metabolism	Ian D. Caterson, Nick Finer et al.	108
10	Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects breakdown →	New England Journal of Medicine	W. P. T. James, Ian D. Caterson et al.	676
11	Clinical Assessment of Pain, Tolerability, and Preference of an Autoinjection Pen Versus a Prefilled Syringe for Patient Self-Administration of the Fully Human, Monoclonal Antibody Adalimumab: The TOUCH Trial	Clinical Therapeutics	Alan Kivitz, Steven M. Cohen et al.	112
12	Prediction of response to sibutramine therapy in obese non‐diabetic and diabetic patients	Diabetes Obesity and Metabolism	Nick Finer, Donna H. Ryan et al.	51
13		The Pediatric Infectious Disease Journal	Xavier Sáez‐Llorens, Richard A. Rode et al.	5
14	Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children	The Pediatric Infectious Disease Journal	Xavier Sáez‐Llorens, Richard A. Rode et al.	102
15	Value of baseline levels in assessing tryptase release	Inflammation Research	James P. Lynch, Cheryl Renz et al.	1
16	Antihistamine prophylaxis permits rapid vancomycin infusion	Critical Care Medicine	Cheryl Renz, Henry A. Finn et al.	48
17	Oral Antihistamines Reduce the Side Effects from Rapid Vancomycin Infusion	Anesthesia & Analgesia	Cheryl Renz, Henry A. Finn et al.	17
18	Tryptase Levels Are Not Increased during Vancomycin-induced Anaphylactoid Reactions	Anesthesiology	Cheryl Renz, D. Laroche et al.	56
19	Histamine release during rapid vancomycin administration	Inflammation Research	Cheryl Renz, James P. Lynch et al.	17
20	Negative co-operativity in glutamate dehydrogenase. Involvement of the 2-position in glutamate in the induction of conformational changes	Biochemical Journal	Ellis Bell, Cheryl Renz et al.	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact